Lindbrook Capital, LLC Aura Biosciences, Inc. Call Options Transaction History
Lindbrook Capital, LLC
- $1.06 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AURA
# of Institutions
95Shares Held
40.4MCall Options Held
6KPut Options Held
6.4K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$42 Million12.68% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.88MShares$29.6 Million0.06% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR3.32MShares$20.1 Million0.67% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$18.4 Million4.98% of portfolio
-
Black Rock Inc. New York, NY3.01MShares$18.2 Million0.0% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $177M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...